Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 13 04:00PM ET
9.20
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.73 Insider Own3.75% Shs Outstand9.30M Perf Week2.79%
Market Cap87.42M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.13M Perf Month0.00%
Income-7.00M PEG- EPS next Q- Inst Own4.08% Short Float0.09% Perf Quarter-15.98%
Sales6.00M P/S14.57 EPS this Y-50.50% Inst Trans- Short Ratio0.49 Perf Half Y-15.52%
Book/sh4.01 P/B2.29 EPS next Y- ROA-20.20% Short Interest0.00M Perf Year-
Cash/sh0.78 P/C11.81 EPS next 5Y- ROE-23.00% 52W Range7.35 - 21.67 Perf YTD-20.24%
Dividend Est.- P/FCF- EPS past 5Y- ROI-23.10% 52W High-57.54% Beta-
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low25.17% ATR (14)0.80
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)50.33 Volatility16.31% 8.25%
Employees40 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-945.30% Payout- Rel Volume0.11 Prev Close9.20
Sales Surprise- EPS Surprise- Sales Q/Q-9.10% EarningsNov 15 AMC Avg Volume7.59K Price9.20
SMA203.88% SMA50-3.51% SMA200-12.03% Trades Volume820 Change0.00%
May-13-24 09:55PM
May-07-24 01:52PM
Apr-17-24 04:05PM
Apr-11-24 04:05PM
Apr-02-24 07:53AM
02:30PM Loading…
Mar-15-24 02:30PM
Feb-12-24 08:00AM
Jan-31-24 09:00AM
Nov-15-23 04:05PM
Nov-08-23 04:05PM
Nov-02-23 04:05PM
Oct-17-23 10:00AM
Oct-11-23 11:10AM
Sep-21-23 09:00AM
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer firm that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology research and development activity. The company was founded in 1997 and is based in Addison, Texas.